"The production of iPS cells from dermal fibroblasts has generated intense interest in the utility of such cells for research purposes and clinical applications. iPS cell production currently requires the use of transcription factor gene delivery to reprogramme cells into iPS cells. Hence, both gene delivery technology and iPS cell characterization and subsequent cell differentiation are critical aspects of iPS cell biology. This meeting will address both issues" Meeting Chairs:  Professor Peter Andrews , University of Sheffield, UK and Dr Chris Denning, University of Nottingham¸UKThe agenda includesInduction of pluripotency in adult stem cellsProfessor Holm Zaehres, Max Planck Institute, GermanyDevelopment of human ES and iPS cell models for Huntington’s Disease Nicholas Allen, Cardiff University, UKHuman ESCs into specific endodermal cell types Dr Ludvic Vallier, Laboratory for Regenerative medicine, University of Cambridge, UKStem cell states and the single cell Professor Peter Andrews, University of Sheffield, UKDerivation and utility of cardiomyocytes from human pluripotent stem cellsDr Chris Denning, University  of Nottingham, UKNovel human iPSC lines for spinal Muscular AtrophyDr Rafael J. Yáñez-Muñoz, Royal Holloway-University of London, UK